Reduced Nicotinamide Mononucleotide (NMNH)
Quick answer: Morgan Chemicals supplies Reduced Nicotinamide Mononucleotide (NMNH) across Pakistan as part of its Nutraceuticals range, with quotations available via info@morgan.pk.
Reduced Nicotinamide Mononucleotide (NMNH) is a cutting-edge derivative of NMN, designed for enhanced bioavailability and stability. Sourced through advanced biochemical synthesis, NMNH acts as a direct precursor to Nicotinamide Adenine Dinucleotide (NAD⁺), a vital coenzyme involved in numerous cellular processes, including energy metabolism, DNA repair, and cellular rejuvenation. By efficiently boosting NAD⁺ levels, NMNH supports healthy aging, promotes cellular resilience, and may contribute to overall vitality and well-being. Its reduced form allows for potentially improved absorption within the body.
Formulators can integrate NMNH into a variety of nutraceutical applications, including dietary supplements such as capsules, tablets, and powders, targeting a growing consumer base interested in healthy aging and longevity solutions. Its versatility also extends to functional foods and specialized beverage formulations. For formulators in Pakistan, Morgan Chemicals offers NMNH as a reliable, high-quality ingredient, enabling them to innovate and meet the increasing demand for advanced nutraceuticals that support cellular health and age-related wellness.
B2B Supply Only
This product is available exclusively for supply to licensed pharmaceutical, food, or industrial companies. Not for individual or consumer sale. Morgan Chemicals is a distributor and does not manufacture this product. For regulatory documentation and pricing, please contact our team.